Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS).

According to the study’s abstract in The Lancet, TAVR with Acurate neo2 failed to meet non-inferiority. It also resulted in ...

Once again, data are suggesting that operators should move cautiously in bicuspid anatomy and think about surgery first.

Recent FDA updates in the areas of cardiac intervention, hypertension and arrhythmia disorders expand the pool of available ...

Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to ...

Pretranscatheter aortic valve replacement-CT angiography safely deferred the need for invasive coronary angiography in 53% of patients, according to a study published May 21 in Circulation: ...

Researchers say the data underscore the need for more aggressive surveillance of patients, even when AS is moderate AS.

Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that ...

For patients with asymptomatic severe aortic stenosis, transcatheter aortic valve replacement was superior to clinical ...

Nagpur: The city is witnessing a significant leap in cardiac care with the increasing use of Transcatheter Aortic Valve ...

Cumberland County Commissioner Gary Eichelberger is recovering from open heart surgery he says will keep him out of the ...

The medical team is performing the aortic valve replacement surgery using advanced techniques at Salman Al-Dubous Cardiac ...